m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05092
|
[1] | |||
Non-coding RNA
piR31115
METTL3
lncRNA miRNA circRNA
Direct
Enhancement
m6A modification
YAP1
YAP1
METTL3
Methylation
: m6A sites
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | Transcriptional coactivator YAP1 (YAP1) | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | piR31115 | piRNA | View Details | ||
| Regulated Target | Methyltransferase-like protein 3 (METTL3) | View Details | |||
| Crosstalk Relationship | ncRNA → m6A | Enhancement | |||
| Crosstalk Mechanism | ncRNAs directly impacts m6A modification through recruiting m6A regulator | ||||
| Crosstalk Summary | Triple negative breast cancer cell derived piR 31115 promotes the proliferation and migration of endothelial cells via METTL3 mediated m6A modification of Transcriptional coactivator YAP1 (YAP1) | ||||
| Responsed Disease | Triple-negative breast cancer | ICD-11: 2C6Z | |||
In-vitro Model |
U2OS | Osteosarcoma | Homo sapiens | CVCL_0042 | |
|
WI-38 VA13 subline 2RA
|
N.A. | Homo sapiens | CVCL_2759 | ||
| CAL-27 | Tongue squamous cell carcinoma | Homo sapiens | CVCL_1107 | ||
| HEK293T | Normal | Homo sapiens | CVCL_0063 | ||
: m6A sites